Prenetics
PublicLast Round
Growth Equity
Jul 14, 2026
Total Funding Raised
$1B
Company Overview
Prenetics is a health sciences company that specializes in consumer and clinical health solutions, including multi-cancer early detection technologies, advanced genomic profiling, and wellness products.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
personalized healthdirect-to-consumerD2Chealth supplementswellness brandat-home genetic testingsubscription healthdiagnostic testingprecision medicinehealth techbiohackingsupplement subscriptionconsumer diagnosticsDNA testingpersonalized nutrition
Prenetics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Prenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 14, 2026 |
Key People
Founding team and executive leadership
Prenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Catalyst's Customer Value Fund | Growth Equity |
Prenetics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersHong Kong S.A.R.
Employee Range224
Year Founded2014
Last FundingJul 14, 2026